Isolated communities are cut off from the outside world and therefore also from supply chains for vital goods such as medicines. Wounds from accidental injury, violence, or simply chronic disease may heal uneventfully but wounds in such isolated and compromised healthcare environments often become infected with antibiotic-resistant microbes and fail to heal especially if the wound has been caused by explosive weapons in conflict or trauma during natural disasters.
Maggot therapy is a highly effective treatment to remove dead tissue and control infection even in the most austere of conditions. However, young medicinal maggots are fragile and, under current best practice, have a short shelf life of 24-48 hours once they leave the production laboratory. They also need to be transported under cool chain conditions between 6 and 25 oC.
This means that traditional hub-and-spokes production and distribution logistics is not feasible for the supply of medicinal maggots to isolated communities.
To address this challenge, MedMagLabs developed: